Cargando…
Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma
Lung cancer is the most commonly diagnosed cancer in the world. “Driver” and “passenger” mutations identified in lung cancer indicate that genetics play a major role in the development of the disease, progression, metastasis and response to therapy. Survival rates for lung cancer treatment have rema...
Autores principales: | Wangari-Talbot, Janet, Hopper-Borge, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952141/ https://www.ncbi.nlm.nih.gov/pubmed/24634705 http://dx.doi.org/10.6000/1929-2279.2013.02.04.5 |
Ejemplares similares
-
Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022) -
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer
por: Tanino, Ryosuke, et al.
Publicado: (2018) -
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
por: Zhou, Kexun, et al.
Publicado: (2023) -
Genetics of melanoma
por: Wangari-Talbot, Janet, et al.
Publicado: (2013) -
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
por: Yanagitani, Noriko, et al.
Publicado: (2020)